These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37201859)

  • 1. Breakthrough invasive fungal infection among patients with haematologic malignancies: A national, prospective, and multicentre study.
    Puerta-Alcalde P; Monzó-Gallo P; Aguilar-Guisado M; Ramos JC; Laporte-Amargós J; Machado M; Martin-Davila P; Franch-Sarto M; Sánchez-Romero I; Badiola J; Gómez L; Ruiz-Camps I; Yáñez L; Vázquez L; Chumbita M; Marco F; Soriano A; González P; Fernández-Cruz A; Batlle M; Fortún J; Guinea J; Gudiol C; García J; Ruiz Pérez de Pipaón M; Alastruey-Izquierdo A; Garcia-Vidal C
    J Infect; 2023 Jul; 87(1):46-53. PubMed ID: 37201859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of Invasive Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: The Turin Experience.
    Busca A; Cinatti N; Gill J; Passera R; Dellacasa CM; Giaccone L; Dogliotti I; Manetta S; Corcione S; De Rosa FG
    Front Cell Infect Microbiol; 2021; 11():805514. PubMed ID: 35071052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
    Jensen RH
    Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology and Antifungal Susceptibility Profile of
    Cho SY; Lee DG; Kim WB; Chun HS; Park C; Myong JP; Park YJ; Choi JK; Lee HJ; Kim SH; Park SH; Choi SM; Choi JH; Yoo JH
    J Clin Microbiol; 2019 Jul; 57(7):. PubMed ID: 31018982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in the epidemiological landscape of invasive mould infections and disease.
    Lass-Flörl C; Cuenca-Estrella M
    J Antimicrob Chemother; 2017 Mar; 72(suppl_1):i5-i11. PubMed ID: 28355462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary antifungal prophylaxis with micafungin in patients with haematological malignancies: real-life data from a retrospective single-centre observational study.
    Nachbaur D; Angelova O; Orth-Höller D; Ditlbacher A; Lackner M; Auberger J; Lass-Flörl C
    Eur J Haematol; 2015 Mar; 94(3):258-64. PubMed ID: 25082655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.
    Moen MD; Lyseng-Williamson KA; Scott LJ
    Drugs; 2009; 69(3):361-92. PubMed ID: 19275278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and risk factors for mortality of invasive non-Aspergillus mould infections in patients with haematologic diseases: A single-centre 7-year cohort study.
    Lee HJ; Cho SY; Lee DG; Park C; Chun HS; Park YJ
    Mycoses; 2020 Mar; 63(3):257-264. PubMed ID: 31762083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breakthrough candidemia after the introduction of broad spectrum antifungal agents: A 5-year retrospective study.
    Breda GL; Tuon FF; Meis JF; Herkert PF; Hagen F; de Oliveira LZ; Dias VC; da Cunha CA; Queiroz-Telles F
    Med Mycol; 2018 Jun; 56(4):406-415. PubMed ID: 29420820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breakthrough Invasive Fungal Infections in Patients With High-Risk Hematological Disorders Receiving Voriconazole and Posaconazole Prophylaxis: A Systematic Review.
    Boutin CA; Durocher F; Beauchemin S; Ziegler D; Abou Chakra CN; Dufresne SF
    Clin Infect Dis; 2024 Jul; 79(1):151-160. PubMed ID: 38752732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-life epidemiology and current outcomes of hospitalized adults with invasive fungal infections.
    Monzó-Gallo P; Chumbita M; Lopera C; Aiello TF; Peyrony O; Bodro M; Herrera S; Sempere A; Fernández-Pittol M; Cuesta G; Simó S; Benegas M; Fortuny C; Mensa J; Soriano A; Puerta-Alcalde P; Marco F; Garcia-Vidal C
    Med Mycol; 2023 Mar; 61(3):. PubMed ID: 36861308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of invasive fungal diseases in cancer patients-Revised 2019 Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
    Ruhnke M; Cornely OA; Schmidt-Hieber M; Alakel N; Boell B; Buchheidt D; Christopeit M; Hasenkamp J; Heinz WJ; Hentrich M; Karthaus M; Koldehoff M; Maschmeyer G; Panse J; Penack O; Schleicher J; Teschner D; Ullmann AJ; Vehreschild M; von Lilienfeld-Toal M; Weissinger F; Schwartz S
    Mycoses; 2020 Jul; 63(7):653-682. PubMed ID: 32236989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology and treatment approaches in management of invasive fungal infections in hematological malignancies: Results from a single-centre study.
    Fracchiolla NS; Sciumè M; Orofino N; Guidotti F; Grancini A; Cavalca F; Freyrie A; Goldaniga MC; Consonni D; Mattiello V; Pettine L; Cortelezzi A
    PLoS One; 2019; 14(5):e0216715. PubMed ID: 31071175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of invasive fungal disease in haematologic patients.
    Souza L; Nouér SA; Morales H; Simões B; Solza C; Queiroz-Telles F; Nucci M
    Mycoses; 2021 Mar; 64(3):252-256. PubMed ID: 33141969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EPICO 3.0. Empirical antifungal therapy in critically-ill hematology patients.
    Llinares P; Ruiz I; Zaragoza R; Ferrer R; Rodríguez AH; Maseda E; Grau S;
    Rev Iberoam Micol; 2016; 33(4):206-215. PubMed ID: 27751781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breakthrough invasive mould infections in patients treated with caspofungin.
    Pang KA; Godet C; Fekkar A; Scholler J; Nivoix Y; Letscher-Bru V; Massias L; Kauffmann-Lacroix C; Elsendoorn A; Uzunov M; Datry A; Herbrecht R
    J Infect; 2012 Apr; 64(4):424-9. PubMed ID: 22227384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Invasive Mold Infections in Patients with Hematologic Malignities: The Effects of Environmental Factors].
    Atilla A; Çelik M; Çolak ÖY; Kuruoğlu T; Temoçin F; Kelkitli E; Birinci A
    Mikrobiyol Bul; 2022 Apr; 56(2):315-325. PubMed ID: 35477233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasive fungal disease in children with acute myeloid leukaemia: An Australian multicentre 10-year review.
    Yeoh DK; Moore AS; Kotecha RS; Bartlett AW; Ryan AL; Cann MP; McMullan BJ; Thursky K; Slavin M; Blyth CC; Haeusler GM; Clark JE
    Pediatr Blood Cancer; 2021 Nov; 68(11):e29275. PubMed ID: 34357688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive Fungal Infections in Patients with Hematological Malignancies: Emergence of Resistant Pathogens and New Antifungal Therapies.
    Gamaletsou MN; Walsh TJ; Sipsas NV
    Turk J Haematol; 2018 Mar; 35(1):1-11. PubMed ID: 29391334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.